LPL Financial LLC Boosts Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

LPL Financial LLC boosted its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 6.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 37,584 shares of the company’s stock after buying an additional 2,127 shares during the period. LPL Financial LLC’s holdings in LifeStance Health Group were worth $277,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. SG Americas Securities LLC raised its stake in shares of LifeStance Health Group by 65.7% during the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock valued at $666,000 after purchasing an additional 35,823 shares during the period. JPMorgan Chase & Co. raised its stake in shares of LifeStance Health Group by 13.0% during the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock valued at $662,000 after purchasing an additional 10,894 shares during the period. Jennison Associates LLC raised its stake in shares of LifeStance Health Group by 278.4% during the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company’s stock valued at $59,597,000 after purchasing an additional 5,949,438 shares during the period. Principal Financial Group Inc. raised its stake in shares of LifeStance Health Group by 6.1% during the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock valued at $28,817,000 after purchasing an additional 235,316 shares during the period. Finally, Handelsbanken Fonder AB purchased a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $128,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Insider Buying and Selling

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. The trade was a 5.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 6.60% of the stock is currently owned by insiders.

LifeStance Health Group Stock Performance

Shares of NASDAQ:LFST opened at $6.53 on Tuesday. The stock has a market capitalization of $2.51 billion, a price-to-earnings ratio of -25.12 and a beta of 1.30. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $8.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The company has a 50 day moving average price of $6.96 and a 200 day moving average price of $7.31.

Analyst Ratings Changes

A number of analysts recently issued reports on LFST shares. William Blair restated an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price target for the company. Finally, KeyCorp initiated coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They set an “overweight” rating and a $9.00 price objective on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, LifeStance Health Group presently has an average rating of “Moderate Buy” and a consensus target price of $8.30.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.